Close search


I specialise in commercial litigation and arbitration, with a particular focus on insurance and reinsurance coverage disputes in which I represent policyholders.

I am a commercial litigator with a particular focus on representing policyholders in coverage disputes against insurers. Over the past decade, I have helped clients ranging from private individuals to global organisations to successfully recover losses from insurers under a range of policies including professional indemnity, product liability/recall, D&O, property, political and credit risk. I have a real interest in the life sciences and pharmaceutical sector, having spent six months working in-house at a global pharmaceutical company. The COVID-19 pandemic and recent “FCA Test Case” has shone a light on some of the issues with the UK insurance industry’s approach to paying claims and I look forward to working with my clients to ensure they recover what they are owed in an ever hardening insurance market.

As well as representing clients the High Court and Court of Appeal, I am a great fan of arbitration as an alternative means of dispute resolution and have acted in both ad hoc and institutional arbitrations, particularly those governed by the LCIA, ICC and SCC Rules.

Outside of work I am mum to a determined toddler who could probably hold her own in the Supreme Court.

Contact Harriet


Dispute Resolution

Commercial Litigation


Group Litigation

Litigation Funding

International Arbitration


  • Acting for a global pharmaceutical company in a series of ad hoc arbitrations against various Bermuda-based insurers relating to the scope of its product liability coverage for “mass tort” personal injury claims in the United States.
  • Representing several hundred SMEs in a High Court action against Clydesdale Bank PLC and National Australia Bank alleging that the banks improperly charged customers break costs and deliberately concealed profit hidden within interest rates.
  • Acting for a captive reinsurance company in LCIA arbitration proceedings relating to a $500 million expropriation loss under a political risk insurance programme.
  • Advising numerous businesses in connection with the scope of their business interruption insurance cover for losses sustained as a result of the COVID-19 pandemic.
  • Advising the directors of a UK Plc in connection with the renewal of their D&O policy wording to ensure the best possible cover.

Our Team

Featured Insights


Contact us